Construction and validation of an efferocytosis-related prognostic signature in lung adenocarcinoma
Authors:
- 14 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (16) , 14577-14596
Abstract
Background Accumulating evidence highlights the potential significance of efferocytosis in tumor progression. This study is directed towards the construction of a prognostic risk model for lung adenocarcinoma (LUAD), grounded on efferocytosis-related genes (ERGs). Methods Employing LASSO-COX regression analysis, a risk-prognostic model was formulated, centered on seven ERGs. Concurrently, a nomogram was established that incorporated patient clinical features and risk scores. The predictive accuracy of the risk model and the nomogram was substantiated via external validation sets. The landscapes of immune infiltration and genetic mutation were evaluated for high- and low-risk groups, with the expression of seven key genes validated through RT-PCR. Results Our findings reveal that the high-risk group displayed considerably inferior survival outcomes in comparison to the low-risk group. A diminished abundance of immune cell infiltrates and a higher prevalence of gene mutations characterized the high-risk group. Genes with high expression were markedly enriched in pathways related to cell proliferation. The superior predictive performance of the risk model and nomogram was adequately substantiated by the external validation sets (GSE31210, GSE30219, and GSE50081). In addition, we discerned several potential therapeutic drugs demonstrating different sensitivities across patient risk groups. The differential expression of seven central genes was confirmed in A549, H1299, and BEAS-2B cell lines. Conclusion The constructed risk model and nomogram display high accuracy in predicting the survival and immune landscape of LUAD patients, thus providing invaluable prognostic tools in clinical scenarios.Keywords
Funding Information
- Key Science and Technology Projects in Henan Province (No. 202102310457, No. 202102310457)
- Henan Province Medical Science and Technology Research plan joint construction project (No. LHGJ20200034, No. LHGJ20200034)
- “23456 Talent Project” of Henan Provincial People’s Hospital
This publication has 49 references indexed in Scilit:
- Understanding the tumor immune microenvironment (TIME) for effective therapyNature Medicine, 2018
- EfferocytosisCurrent Biology, 2016
- Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancerCell Death & Differentiation, 2016
- Emerging role of CD300 receptors in regulating myeloid cell efferocytosisMolecular & Cellular Oncology, 2015
- p85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppressionNature Communications, 2014
- Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA PatientsJournal of Thoracic Oncology, 2014
- Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung CancersScience Translational Medicine, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung AdenocarcinomasCancer Research, 2012
- HMGB1 inhibits macrophage activity in efferocytosis through binding to the αvβ3-integrinAmerican Journal of Physiology-Cell Physiology, 2010